Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B T Adornato

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Laboratory and Clinical Medicine|October 1, 1982
Quantification of acute phase reactants after muscle biopsyR J Elin, M Foidart, B T Adornato, et al.
The New England Journal of Medicine|April 13, 1978
Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapyN Peylan-Ramu, D G Poplack, P A Pizzo, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1982
Effect of heme administration on hemopexin metabolism in the rhesus monkeyM Foidart, J Eiseman, W K Engel, et al.
Neurology|September 25, 1998
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study GroupS C Apfel, J A Kessler, B T Adornato, et al.
Journal of Neuro-Oncology|March 1, 1993
Intracranial myxopapillary ependymoma: case reportR E Warnick, J Raisanen, B T Adornato, et al.
Annals of Neurology|August 1, 1994
The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsB G Petty, D R Cornblath, B T Adornato, et al.
JAMA|November 1, 2000
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator GroupS C Apfel, S Schwartz, B T Adornato, et al.
Neurology|October 28, 2011
The practice of neurology, 2000-2010: report of the AAN Member Research SubcommitteeB T Adornato, O Drogan, P Thoresen, et al.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Laboratory and Clinical Medicine|October 1, 1982
Quantification of acute phase reactants after muscle biopsyR J Elin, M Foidart, B T Adornato, et al.
The New England Journal of Medicine|April 13, 1978
Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapyN Peylan-Ramu, D G Poplack, P A Pizzo, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1982
Effect of heme administration on hemopexin metabolism in the rhesus monkeyM Foidart, J Eiseman, W K Engel, et al.
Neurology|September 25, 1998
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study GroupS C Apfel, J A Kessler, B T Adornato, et al.
Journal of Neuro-Oncology|March 1, 1993
Intracranial myxopapillary ependymoma: case reportR E Warnick, J Raisanen, B T Adornato, et al.
Annals of Neurology|August 1, 1994
The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsB G Petty, D R Cornblath, B T Adornato, et al.
JAMA|November 1, 2000
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator GroupS C Apfel, S Schwartz, B T Adornato, et al.
Neurology|October 28, 2011
The practice of neurology, 2000-2010: report of the AAN Member Research SubcommitteeB T Adornato, O Drogan, P Thoresen, et al.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.
Pageof 3